Written and maintained by CASRAI Editorial Board
Last updated
Short answer: Inventory management in healthcare is the control of clinical and laboratory supplies from the moment they arrive until they are used, expire, or run short. This guide treats it as one lifecycle (receive, identify, store, count, replenish, expire or dispose, respond to shortages) and shows, stage by stage, what a record must capture and which published source sits behind it. It is general information for hospital, clinic and laboratory staff, not clinical advice.
Definition and scope
In a hospital, clinic or laboratory, inventory management means knowing what supplies are on hand, where they are, what state they are in, and when they will run out. It covers consumables (reagents, dressings, syringes), not the tracking of durable equipment, which is a separate discipline covered in biomedical equipment inventory tracking, tagging and lifecycle. Questions about inventory management hospital and inventory management in a clinic or lab share the same lifecycle; what differs is the regulation attached to each stage. Of the sources used here, only the laboratory rule (CLIA, 42 CFR 493.1252) is written for laboratories specifically.
The lifecycle below is an editorial framework used to organise the sources. It is not a regulatory term, and no source cited here prescribes these exact seven stages.
How inventory moves through a facility
| Stage | What the record should capture (editorial) | Source behind it |
|---|---|---|
| Identify and receive | Device or product identity, plus lot or batch and expiration date where the label carries them | FDA UDI Basics |
| Store | Defined storage conditions (for example temperature or humidity) and evidence they were monitored | 42 CFR 493.1252(b) |
| Label | Identity, concentration where relevant, storage requirements, preparation and expiration dates | 42 CFR 493.1252(c) |
| Use or discard | Nothing used past expiry, after deterioration, or if of substandard quality | 42 CFR 493.1252(d) |
| Shortage response | Which items have no easy substitute, and whether the item is on FDA’s shortage list | FDA Medical Device Supply Chain and Shortages |
Counting and replenishment are the two stages where facilities choose a method rather than follow a rule; they are covered in the next sections and in linked pages.
Identify and label: what a UDI does and does not tell you
The FDA describes a unique device identifier (UDI) as a unique numeric or alphanumeric code. It has two parts. The device identifier (DI) is a mandatory, fixed portion that identifies the labeler and the specific model or version. The production identifier (PI) is a conditional, variable portion that can carry the lot or batch number, serial number, expiration date or manufacture date. (FDA, UDI Basics, checked 2026-11-01.)
The practical consequence, which is our reading and not an FDA statement about inventory, is that a scan of the DI tells a system what the product is, while lot and expiry exist only if the PI is present on the label and is captured. A stock record keyed on the DI alone can show a healthy quantity while hiding that part of it is near expiry. The FDA page describes the purpose of UDI as identifying devices from manufacturing through distribution to patient use; it does not itself discuss inventory systems.
Storage and expiry rules for laboratories (CLIA)
For laboratories regulated under CLIA, 42 CFR 493.1252 sets out requirements that map directly onto inventory records (Cornell LII, checked 2026-11-01):
- Storage conditions. The laboratory must define criteria for conditions essential for proper storage of reagents and specimens, consistent with the manufacturer’s instructions, and monitor and document conditions such as temperature, humidity and water quality where applicable (paragraph b).
- Labeling. Reagents, solutions, culture media, control materials, calibration materials and other supplies, as appropriate, must be labeled with identity, concentration or strength when relevant, storage requirements, and preparation and expiration dates (paragraph c).
- Expiry. These items must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality (paragraph d).
The rule does not require a date-received label, and it does not specify a counting method or stock levels. How a laboratory proves that expired stock was removed is a local procedure choice.
Replenishment methods compared (and where to read more)
Methods for deciding when and how much to reorder are well developed elsewhere on this site. Use these pages rather than a single rule of thumb:
- Par level and its pharmacy application in par level in pharmacy.
- Kanban inventory and just-in-time inventory.
- Consignment versus vendor-managed inventory.
- Outcome measures: stockout and fill rate.
- Software that supports these workflows: medical inventory management software.
When supply is short: FDA shortage tools
The FDA states that shortages of medical devices can occur for many reasons, including manufacturing and quality problems, geopolitical issues, natural disasters and public health emergencies (FDA, Medical Device Supply Chain and Shortages, checked 2026-11-01). Three points from that page are useful to inventory staff:
- Under section 506J, manufacturers of certain devices must notify FDA of a permanent discontinuance or an interruption that could meaningfully disrupt domestic supply during, or in advance of, a public health emergency. Such notifications are not required outside a public health emergency, so a quiet notification record is not evidence that supply is safe.
- FDA publishes a 506J Device List (by product code) and a Medical Device Shortages List.
- Facilities having trouble obtaining devices are asked to email [email protected].
For the wider logistics picture, see medical supply logistics.
Common misunderstandings
- “A barcode scan gives us expiry.” Only if the code carries the production identifier. The DI alone does not.
- “CLIA governs all hospital inventory.” 42 CFR 493.1252 applies to laboratory reagents and supplies; it should not be cited as a rule for dressings or syringes.
- “No FDA notice means no shortage.” Section 506J notifications are not required outside a public health emergency.
- “Inventory management is just reordering.” Storage monitoring, labeling and expiry control are part of the same process in the laboratory rule above.
FAQ
What is inventory management in healthcare?
It is controlling clinical and laboratory supplies across their life in a facility: receiving, identifying, storing, counting, replenishing, retiring expired stock and responding to shortages.
Is inventory management in a hospital different from a clinic or lab?
The lifecycle is the same. The attached rules differ: for laboratories, CLIA 42 CFR 493.1252 adds storage, labeling and expiry requirements; the sources used here do not set separate inventory rules for hospitals or clinics.
Which identifiers should be captured at receipt?
Per FDA UDI Basics, the DI identifies the product and the PI can carry lot or batch, serial number and expiration or manufacture date. Whether to record each at receipt is a facility decision.
Where does FDA list device shortages?
On its Medical Device Supply Chain and Shortages page, which links the Medical Device Shortages List and the 506J Device List.
Sources
- 42 CFR 493.1252, Standard: Test systems, equipment, instruments, reagents, materials, and supplies. Cornell Legal Information Institute, checked 2026-11-01.
- U.S. Food and Drug Administration, UDI Basics, checked 2026-11-01.
- U.S. Food and Drug Administration, Medical Device Supply Chain and Shortages, checked 2026-11-01.
